- Instruments
- Reagents
- Services and Software
Liquid Biopsy Market size was valued at USD 891.076 million in 2022 and is expected to reach USD 2953.83 million by 2029, at a CAGR of 21.6% from 2023-2029. The market is gaining traction in recent times owing to its accurate, effective results in comparison with traditional cancer screening methods, which are achieved through minimal invasiveness and expenses. Challenges associated with traditional biopsies such as invasiveness, ill-informed results, post-sampling medical challenges, and costs are prompting healthcare professionals to adopt less invasive liquid biopsy tests for cancer screening and management, which is projected to create significant market demand for liquid biopsy products and services over the forecast period. Moreover, several clinical research activities related to biomarkers are in the late stage and it is expected that upon successful launch and commercialization of these tests over the forecast period will result in significant market growth. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. In addition, This report includes new product introductions; regulatory scenarios, and competition analyses with a vividly illustrated competition dashboard to assess the market competition.
Liquid Biopsy Market Summary
Study Period
2023-29
Base Year
2022
CAGR
21.6%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Liquid Biopsy Market Dynamics
Players in the global liquid biopsy market increasingly attracting the investments in recent times for development and commercialization of late-stage products through IPOs. For instance, RainDance Technologies and Biocept filled IPOs in 2015 and 2014 respectively to develop advanced liquid biopsy technologies to aid physicians to devise suitable treatment strategies. Moreover, growing awareness among key stakeholders regarding liquid biopsy assays expected to drive market demand for these tests over the forecast period across the globe.
North-America Got Significant Share
Liquid Biopsy Market Regional Analysis
North America market expected to hold the higher revenue share in global liquid biopsy market and projected to remain same over the forecast period owing to accessibility, availability of advanced diagnostic tools such as liquid biopsy in the region. Asia-pacific liquid biopsy market projected to grow at significant CAGR over the forecast period in comparison with other regions owing to large medical unmet need in the region.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- Liquid Biopsy Market report provides granular level information about the market size, regional market share, historic market (2018 to 2022), and forecast (2023 to 2029)
- The report covers in-detail insights into the competitor’s overview, company share analysis, key market developments, and key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and startup’s details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
- The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Liquid Biopsy Market Segmentation
By Product Type
By Sample
- Blood Samples
- Urine Samples
- Other Biofluid Samples
By Application
- Breast Cancer
- Colorectal Cancer
- Gastrointestinal Cancer
- Leukemia
- Lung Cancer
- Prostate Cancer
- Other Cancers
By End User
- Hospitals
- Diagnostic Laboratories
- Academic and Research Institutes
Frequently Asked Questions
The liquid biopsy market size was valued at USD 891.076 million in 2022
The liquid biopsy market's key players are: Catabasis Pharmaceuticals Inc. NS Pharma, Inc Marathon Pharmaceuticals, LLC ITALFARMACO S.p.A. FibroGen, Inc. Summit Therapeutics plc PTC Therapeutics Santhera Pharmaceuticals Sarepta Therapeutics, Inc.
The liquid biopsy market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1. Executive summary |
| 2. Global Liquid Biopsy Market Introduction |
| 2.1. Global Liquid Biopsy Market – Taxonomy |
| 2.2. Global Liquid Biopsy Market –Definitions |
| 2.2.1. By Product Type |
| 2.2.2. By Application Type |
| 2.2.3. By Sample Type |
| 2.2.4. By End User |
| 3. Global Liquid Biopsy Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Liquid Biopsy Market Dynamics – Factors Impact Analysis |
| 3.6. Global Liquid Biopsy Market – Regulations |
| 3.6.1. The U.S. |
| 3.6.2. Europe |
| 3.7. Federal Grants for Liquid Biopsy Startups |
| 3.8. Venture Capital Investments in Liquid Biopsy Companies |
| 3.9. Product Innovations |
| 3.10. Startups working in the Liquid Biopsy |
| 3.11. Novel Applications of Liquid Biopsy |
| 4. Global Liquid Biopsy Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Liquid Biopsy Market, By Product Type, 2018 - 2022 and Forecast, 2023 - 2029 |
| 5.1. Consumables |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Instruments |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6. Global Liquid Biopsy Market, By Sample Type, 2018 - 2022 and Forecast, 2023 - 2029 |
| 6.1. Blood |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Urine |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3. Others |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7. Global Liquid Biopsy Market Forecast, By Application Type, 2018 - 2022 and Forecast, 2023 - 2029 |
| 7.1. Lung Cancer |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Breast Cancer |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Colorectal Cancer |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Prostate Cancer |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Liver Cancer |
| 7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Others |
| 7.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.6.3. Market Opportunity Analysis |
| 8. Global Liquid Biopsy Market Forecast, By End User Type, 2018 - 2022 and Forecast, 2023 - 2029 |
| 8.1. Hospitals |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Diagnostic Laboratories |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Academic and Research Centers |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Others |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9. Global Liquid Biopsy Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 |
| 9.1. North America |
| 9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia-Pacific |
| 9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Latin America |
| 9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Middle East and Africa |
| 9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 9.6. Global Liquid Biopsy Market - Opportunity Analysis Index, By Product Type, By Application Type, Sample Type, End User, and Region, 2023 - 2029 |
| 10. North America Liquid Biopsy Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 |
| 10.1. By Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Consumables |
| 10.1.2. Instruments |
| 10.2. By Sample Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Blood |
| 10.2.2. Urine |
| 10.2.3. Others |
| 10.3. Application Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Lung Cancer |
| 10.3.2. Breast Cancer |
| 10.3.3. Colorectal Cancer |
| 10.3.4. Prostate Cancer |
| 10.3.5. Liver Cancer |
| 10.3.6. Others |
| 10.4. End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Hospitals |
| 10.4.2. Diagnostic Laboratories |
| 10.4.3. Academic and Research Centers |
| 10.4.4. Others |
| 10.5. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.5.1. U.S. |
| 10.5.2. Canada |
| 10.6. North America Liquid Biopsy Market - Opportunity Analysis Index, By Product Type, By Application Type, By Sample Type, End User and Country, 2023 - 2029 |
| 10.7. North America Liquid Biopsy Market Dynamics – Trends |
| 11. Europe Liquid Biopsy Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 |
| 11.1. By Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Consumables |
| 11.1.2. Instruments |
| 11.2. By Sample Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Blood |
| 11.2.2. Urine |
| 11.2.3. Others |
| 11.3. Application Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Lung Cancer |
| 11.3.2. Breast Cancer |
| 11.3.3. Colorectal Cancer |
| 11.3.4. Prostate Cancer |
| 11.3.5. Liver Cancer |
| 11.3.6. Others |
| 11.4. End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Hospitals |
| 11.4.2. Diagnostic Laboratories |
| 11.4.3. Academic and Research Centers |
| 11.4.4. Others |
| 11.5. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.5.1. Germany |
| 11.5.2. UK |
| 11.5.3. France |
| 11.5.4. Spain |
| 11.5.5. Italy |
| 11.5.6. Russia |
| 11.5.7. Poland |
| 11.5.8. Holland |
| 11.5.9. Rest of Europe |
| 11.6. Europe Liquid Biopsy Market - Opportunity Analysis Index, Opportunity Analysis Index, By Product Type, By Application Type, By Sample Type, End User and Country, 2023 - 2029 |
| 11.7. Europe Liquid Biopsy Market Dynamics – Trends |
| 12. Asia-Pacific Liquid Biopsy Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 |
| 12.1. By Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Consumables |
| 12.1.2. Instruments |
| 12.2. By Sample Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Blood |
| 12.2.2. Urine |
| 12.2.3. Others |
| 12.3. Application Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Lung Cancer |
| 12.3.2. Breast Cancer |
| 12.3.3. Colorectal Cancer |
| 12.3.4. Prostate Cancer |
| 12.3.5. Liver Cancer |
| 12.3.6. Others |
| 12.4. End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Hospitals |
| 12.4.2. Diagnostic Laboratories |
| 12.4.3. Academic and Research Centers |
| 12.4.4. Others |
| 12.5. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.5.1. Japan |
| 12.5.2. China |
| 12.5.3. India |
| 12.5.4. ASEAN |
| 12.5.5. Australia & New Zealand |
| 12.5.6. Rest of Asia-Pacific |
| 12.6. Asia-Pacific Liquid Biopsy Market - Opportunity Analysis Index, By Product Type, By Application Type, By Sample Type, End User and Country, 2023 - 2029 |
| 12.7. Asia-Pacific Liquid Biopsy Market Dynamics – Trends |
| 13. Latin America Liquid Biopsy Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 |
| 13.1. By Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Consumables |
| 13.1.2. Instruments |
| 13.2. By Sample Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1. Blood |
| 13.2.2. Urine |
| 13.2.3. Others |
| 13.3. Application Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. Lung Cancer |
| 13.3.2. Breast Cancer |
| 13.3.3. Colorectal Cancer |
| 13.3.4. Prostate Cancer |
| 13.3.5. Liver Cancer |
| 13.3.6. Others |
| 13.4. End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Hospitals |
| 13.4.2. Diagnostic Laboratories |
| 13.4.3. Academic and Research Centers |
| 13.4.4. Others |
| 13.5. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.5.1. Brazil |
| 13.5.2. Mexico |
| 13.5.3. Argentina |
| 13.5.4. Venezuela |
| 13.5.5. Rest of Latin America |
| 13.6. Latin America Liquid Biopsy Market - Opportunity Analysis Index, By Product Type, By Application Type, By Sample Type, End User and Country, 2023 - 2029 |
| 13.7. Latin America Liquid Biopsy Market Dynamics – Trends |
| 14. Middle East and Africa Liquid Biopsy Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 |
| 14.1. By Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1. Consumables |
| 14.1.2. Instruments |
| 14.2. By Sample Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1. Blood |
| 14.2.2. Urine |
| 14.2.3. Others |
| 14.3. Application Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.3.1. Lung Cancer |
| 14.3.2. Breast Cancer |
| 14.3.3. Colorectal Cancer |
| 14.3.4. Prostate Cancer |
| 14.3.5. Liver Cancer |
| 14.3.6. Others |
| 14.4. End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 14.4.1. Hospitals |
| 14.4.2. Diagnostic Laboratories |
| 14.4.3. Academic and Research Centers |
| 14.4.4. Others |
| 14.5. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 14.5.1. Gulf Cooperation Council (GCC) Countries |
| 14.5.2. Israel |
| 14.5.3. South Africa |
| 14.5.4. Rest of MEA |
| 14.6. MEA Liquid Biopsy Market - Opportunity Analysis Index, By Product Type, By Application Type, By Sample Type, End User and Country, 2023 - 2029 |
| 14.7. MEA Liquid Biopsy Market Dynamics – Trends |
| 15. Competition Landscape |
| 15.1. Strategic Dashboard of Top Market Players |
| 15.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 15.2.1. Catabasis Pharmaceuticals Inc. |
| 15.2.2. NS Pharma, Inc |
| 15.2.3. Marathon Pharmaceuticals, LLC |
| 15.2.4. ITALFARMACO S.p.A. |
| 15.2.5. FibroGen, Inc. |
| 15.2.6. Summit Therapeutics plc |
| 15.2.7. PTC Therapeutics |
| 15.2.8. Santhera Pharmaceuticals |
| 15.2.9. Sarepta Therapeutics, Inc. |
| 16. Research Methodology |
| 17. Key Assumptions and Acronyms |
- Catabasis Pharmaceuticals Inc.
- NS Pharma, Inc
- Marathon Pharmaceuticals, LLC
- ITALFARMACO S.p.A.
- FibroGen, Inc.
- Summit Therapeutics plc
- PTC Therapeutics
- Santhera Pharmaceuticals
- Sarepta Therapeutics, Inc.